Rocket Lab's Vertically Integrated Gambit: The Iridium Bet That Could Redefine the Company
Published on 08/13/2026 at 13:31 | Redaktion boerse-global.de
The phrase "self-licking ice cream" is not one investors typically hear from a CEO describing their own company. But Peter Beck, Rocket Lab's founder and chief executive, deployed it deliberately when outlining his vision: a business that builds the rockets, the satellites that ride them, and eventually the services those satellites deliver. That circular logic now has a price tag attached — roughly $8 billion, to be precise.
The proposed acquisition of Iridium, announced via an 8-K filing with US regulators on Thursday, represents the clearest signal yet that Rocket Lab intends to transform itself from a launch provider into a vertically integrated space conglomerate. The deal, contracted on June 28, would bring Iridium's constellation of 66 satellites, more than 2.5 million subscribers, and annual revenue exceeding $870 million into the Rocket Lab fold. This is not a side project; it is a second pillar.
The Price of Ambition
Iridium shareholders are set to receive $27.00 in cash plus between 0.24 and 0.40 Rocket Lab shares for each of their shares. A bridge loan of $3.6 billion at roughly eight percent interest will fund part of the transaction — a substantial obligation for a company that remains firmly in the red.
The pro-forma figures filed with the SEC illustrate the scale of the wager. For the first half of 2026, the combined entity would have generated $878.7 million in revenue against a net loss of $154.7 million. Full-year 2025 numbers would have shown $1.47 billion in sales with a $203 million loss. Those figures frame the central tension: Rocket Lab is buying scale, but the path to profitability remains distant.
The market's initial response was enthusiastic — shares jumped nearly 16 percent on the Nasdaq on announcement day. That euphoria has since cooled to a more measured assessment, with the stock trading down 2.8 percent at €68.40 on Thursday, roughly eight percent below its 50-day moving average.
Should investors sell immediately? Or is it worth buying Rocket Lab?
A Contract Bonanza Offsets Neutron Anxiety
While the Iridium deal dominates headlines, Rocket Lab has been quietly assembling a defense and infrastructure pipeline that extends well beyond its flagship Neutron rocket. The US Space Force awarded the company a $397 million contract under the Space-Based Airborne Moving Target Indicator program, arriving just days after Rocket Lab secured its largest-ever launch agreement — a multi-launch deal valued at $266 million.
The company also unveiled GHOST, a container-based launch system designed for suborbital and orbital missions from virtually anywhere on the globe, with the Pacific Spaceport Complex in Kodiak, Alaska, serving as the initial site. Meanwhile, the newly established Rocket Lab Germany GmbH, built on the earlier Mynaric acquisition in Munich, aims to expand satellite and component manufacturing for European sovereign space capabilities — a move timed to Germany's pledge to invest more than $40 billion in space and defense by 2030.
This flurry of announcements in early August helped lift the stock 6.8 percent on the week, closing Wednesday at €70.40. The technical picture appears balanced: the RSI sits at 54.2, squarely between overbought and oversold territory, suggesting neither euphoria nor panic is currently priced in.
The Neutron Question Lingers
For all the contract wins, Neutron remains the elephant in the room. The reusable rocket, designed to compete directly with SpaceX's Falcon 9 in the medium-lift segment, has slipped repeatedly since 2024. During the second-quarter earnings call, management signaled fresh risk: while delivery to the launch pad remains on track for the fourth quarter, a first flight in 2026 was no longer confirmed — pushing expectations for the debut to 2027.
That uncertainty weighs heavily because Neutron represents the vehicle through which Rocket Lab intends to monetize a manifest already carrying multiple firm missions over several years. The Archimedes engine has completed over 400 hot-fire tests, and the full engine set for the first Neutron rocket is entering production — but hardware progress has not yet translated into a committed launch date.
Analyst Tim Farrar voiced what many in the sector think but rarely state so bluntly: Rocket Lab and AST SpaceMobile are following SpaceX's playbook while carrying "very inflated valuations," with Neutron delays compounding the risk.
Wall Street's Divided Verdict
Despite the caution, most sell-side analysts remain constructive. Cantor Fitzgerald raised its price target on Thursday from $96 to $122, maintaining an Overweight rating and citing better-than-expected quarterly revenue. Other firms — Roth Capital, Craig Hallum, KeyCorp, and TD Cowen — have targets ranging from $120 to $135. The consensus sits near $110.65 with a "Moderate Buy" rating, though the average target across all analysts is €96.41, roughly 37 percent above current levels.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
The second quarter itself delivered a record $234.07 million in revenue, up 62 percent year over year, with backlog climbing to $2.36 billion. But the bottom line missed expectations: the per-share loss of 8 cents came in above the 6-to-7-cent consensus, and management guided third-quarter revenue to between $250 million and $265 million.
One detail worth noting: Beck himself sold nearly one million shares in early July at $82.86 — a transaction investors may file away without overinterpreting.
A High-Beta Wager on Integration
The stock's trajectory tells its own story. At €70.40, shares sit 47 percent below the May 27 high of €133.80, yet remain 91 percent above their level from twelve months ago. With annualized 30-day volatility at 85 percent, this remains a sentiment-driven, high-beta equity where headlines move prices sharply in either direction.
The broader question is whether Rocket Lab can become the self-sustaining enterprise Beck envisions — or whether the Iridium acquisition adds debt and complexity faster than it adds value. The answer will only emerge once Iridium is fully integrated and Neutron actually flies. Until then, the stock remains a mirror of that open question, with all the swings that entails.
Ad
Rocket Lab Stock: New Analysis - 13 August
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
